Trapelo™ assures that each lab order is precisely determined by the characteristics of each patient’s tumor, and is supported by up-to-date clinical evidence, eliminating the need for prior authorization for molecular medicine. This reduces unnecessary costs while expediting and streamlining the process.  

 

• Comprehensive: Effective for all solid tumors 

• Connected: Integrated with providers and labs

• Convenient: Accessible from within your own portal

​